Shares of Field Trip Health Ltd. (TSE:FTRP – Get Free Report) rose 5.8% during mid-day trading on Monday . The stock traded as high as C$1.11 and last traded at C$1.09. Approximately 97,451 shares were traded during trading, an increase of 165% from the average daily volume of 36,819 shares. The stock had previously closed at C$1.03.
Field Trip Health Stock Performance
The company has a current ratio of 8.20, a quick ratio of 7.70 and a debt-to-equity ratio of 43.39. The firm has a fifty day moving average of C$1.09. The company has a market capitalization of C$12.68 million and a P/E ratio of -1.22.
About Field Trip Health
Field Trip Health Ltd. engages in the development and delivery of psychedelic- assisted therapies in North America. The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; operates Field Trip Discovery, a drug development division that develops the next generation of psychedelic molecules; and provides ketamine-assisted therapy for the treatment of depression, anxiety, addiction, and other conditions.
Read More
- Five stocks we like better than Field Trip Health
- How to Invest in Blue Chip Stocks
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- 3 Warren Buffett Stocks to Buy Now
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Receive News & Ratings for Field Trip Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Field Trip Health and related companies with MarketBeat.com's FREE daily email newsletter.
